Celldex Therapeutics Inc (USD)
CLDX
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range12.42 | 12.90
52-Wk Range- | -
Last Close12.61
Mkt Cap (m)489.62
Dividend yield-
ISINUS15117B2025
Volume466,918.00
Exchange VenueNAS

Company Profile

Celldex Therapeutics Inc is a biopharmaceutical company. The company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.

Key Information
Price/Earning-
Price/Book5.85
Price/Sales40.82
P/CF-
Rev Growth (3 year avg)-19.25
EPS Growth (3 year avg)-
Operating Margin % -1,526.03
Net Margin %-1,423.96
Return on Equity-46.66
Debt/Equity0.04

Documents

Prospectus
en 17/06/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.celldex.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)3.595.486.7912.749.543.57
Operating Income (m)-122.43-129.54-132.92-109.33-76.40-54.53
Net Income (m)-118.08-127.20-128.53-93.03-151.18-50.88
Basic EPS-19.80-19.65-19.05-10.80-14.48-3.51
Avg. Diluted Shares Outstanding (m)5.966.476.778.5710.4414.51
Balance Sheet
USD201420152016201720182019
Current Assets (m)204.99294.94195.57144.7699.0866.70
Non Current Assets (m)43.0342.65187.79170.8756.7356.24
Total Assets (m)248.01337.58383.36315.62155.81122.93
Current Liabilities (m)24.4930.2435.2227.7412.6011.64
Total Liabilities (m)------
Total Equity (m)211.66290.11265.43236.37124.0694.03
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-101.54-98.89-113.04-99.93-75.24-46.42
Capital Expenditure (m)-1.93-4.88-2.75-1.79-0.81-0.73
Figures are quoted in USD unless stated otherwise
-0.04 (-0.32%)
$
12.57
Last Price